Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Inter Partes Review Petitions for Actelion Pharmaceuticals Ltd.

Successfully counseled Allschwil, Switzerland-based Actelion Pharmaceuticals Ltd. in petitions for Inter Partes Review (IPR), Nos. IPR2015-00561,-00562, resulting in the Patent Trial and Appeal Board initiating trial in August 2015 on patents covering micronized tadalafil drug formulations, and finding all claims unpatentable in final written decisions issued on August 3, 2016.